Use of BTK Inhibitors in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): A Practical Guidance

por St-Pierre, Frédérique, Ma, Shuo
Publicado 2022

Harnessing Natural Killer Cells in Cancer Immunotherapy: A Review of Mechanisms and Novel Therapies

por St-Pierre, Frederique, Bhatia, Shailender, Chandra, Sunandana
Publicado 2021

Poster: CLL-211 Humoral Immune Response Following COVID-19 Vaccination in Patients With Chronic Lymphocytic Leukemia (CLL) and Indolent Non-Hodgkin Lymphoma (NHL): Results From a L...

por St-Pierre, Frédérique, Doukas, Peter, Boyer, Jennifer, Nieves, Mariana, Ma, Shuo
Publicado 2022

CLL-211 Humoral Immune Response Following COVID-19 Vaccination in Patients With Chronic Lymphocytic Leukemia (CLL) and Indolent Non-Hodgkin Lymphoma (NHL): Results From a Large, Si...

por St-Pierre, Frédérique, Doukas, Peter, Boyer, Jennifer, Nieves, Mariana, Ma, Shuo
Publicado 2022

Impact of the COVID-19 pandemic on internal medicine training in the United States: results from a national survey

por St-Pierre, Frederique, Petrosyan, Romela, Gupta, Arjun, Hughes, Stephen, Trickett, John, Read, Susan, Van Doren, Vanessa, Zeveney, Andrew, Shoushtari, Christiana
Publicado 2023

Phase I study of novel SYK inhibitor TAK‐659 (mivavotinib) in combination with R‐CHOP for front‐line treatment of high‐risk diffuse large B‐cell lymphoma

por Karmali, Reem, St‐Pierre, Frederique, Ma, Shuo, Foster, Kelly D., Kaplan, Jason, Mi, Xinlei, Pro, Barbara, Winter, Jane N., Gordon, Leo I.
Publicado 2022

Humoral Immunity After COVID-19 Vaccination in Chronic Lymphocytic Leukemia and Other Indolent Lymphomas: A Single-Center Observational Study

por Doukas, Peter G, St. Pierre, Frederique, Karmali, Reem, Mi, Xinlei, Boyer, Jennifer, Nieves, Mariana, Ison, Michael G, Winter, Jane N, Gordon, Leo I, Ma, Shuo
Publicado 2023